Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2001

View Archived Issues

Aurora and R.W. Johnson expand ion channel technology agreement

Warning issued regarding Zerit/Videx combination therapy use in pregnant women

Cambridge NeuroScience receives SBIR grant related to peripheral nerve dysfunction

European commercialization license for Cidecin granted to Gilead

Cell Therapeutics outlines 2001 goals

Anticocaine catalytic MAb selectively attenuates cocaine selfadministration in rats

Neurogen and Pfizer extend collaboration related to GABA system

Coronary artery stenosis prevented by TAS-301 in pigs with balloon overstretch injury

BioChem Pharma completes acquisition of CliniChem

Efficacy and safety of JAK3 inhibitors in allergic asthma validated using WHI-P97

Oxford BioMedica develops Lentivector transport technology with neurological applications

FDA issues nonapprovable letter for Atragen; company plans to continue development

Four-year PROactive study examines effects of Actos on cardiovascular risk

Wide series of CDK/cyclin inhibitors developed at Pharmacia

Symbicort combination asthma product approved in E.U.

Short-acting benzodiazepines and their use claimed by Glaxo (GlaxoSmithKline)

Inhibitors of essential bacterial enzymes disclosed in recent patent

Benzimidazole-based antibacterial agents in the GlaxoSmithKline pipeline

New substance P antagonists particularly useful for emesis

Several related classes of anticoagulants, their preparation, activity and use reported

Matrix completes NDA filing for IntraDose injectable gel

Important Japanese approvals received and pending for AstraZeneca

Zometa granted positive opinion from CPMP

IND submitted for salmon calcitonin as oral osteoporosis treatment

Phytopharm reports promising clinical trial results for P-54 in colorectal cancer

Potent new nonpeptide ORL1 receptor agonist discovered at Novo Nordisk

Novogen begins second phase I trial of anticancer agent in Australia

Ferring designs very-long-acting GnRH antagonist with other advantageous properties

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...